{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Princeton",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA076477"
        ],
        "brand_name": [
          "ATORVASTATIN CALCIUM"
        ],
        "generic_name": [
          "ATORVASTATIN CALCIUM"
        ],
        "manufacturer_name": [
          "Sun Pharmaceutical Industries Inc."
        ],
        "product_ndc": [
          "63304-827",
          "63304-828",
          "63304-829",
          "63304-830"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ATORVASTATIN CALCIUM TRIHYDRATE"
        ],
        "rxcui": [
          "259255",
          "617310",
          "617311",
          "617312"
        ],
        "spl_id": [
          "24508d3d-eec0-4c5c-bfaa-d6e01a03fe80"
        ],
        "spl_set_id": [
          "595ab888-6b55-4642-a32f-e8521821ed81"
        ],
        "package_ndc": [
          "63304-827-90",
          "63304-827-05",
          "63304-828-90",
          "63304-828-05",
          "63304-829-90",
          "63304-829-05",
          "63304-830-90",
          "63304-830-05"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "48A5M73Z4Q"
        ]
      },
      "product_type": "Drugs",
      "event_id": "63759",
      "recalling_firm": "Ranbaxy Inc.",
      "address_1": "600 College Rd E Ste 2100",
      "address_2": "N/A",
      "postal_code": "08540-6636",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and PR",
      "recall_number": "D-070-2013",
      "product_description": "Atorvastatin Calcium Tablets, 10 mg, 90 tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257, USA, by: Ranbaxy Laboratories Ltd., New Delhi - 110019, India, NDC #: 63304-827-90",
      "product_quantity": "120,201 Bottles",
      "reason_for_recall": "Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.",
      "recall_initiation_date": "20121109",
      "center_classification_date": "20121129",
      "termination_date": "20140428",
      "report_date": "20121205",
      "code_info": "Lot #s: 2436144, 2436582, 2441567, 2441568, Exp 08/31/2014."
    }
  ]
}